ETP nanomedicines working groups annual meeting, Madrid, Spain
The meeting will cover the following topics:
- status of the research on nanomedicines;
- commercialising macromolecular drugs;
- neurodegenerative diseases: current situation, advancements and limitations;
- nanotechnology-based diagnosis;
- regeneration;
- nanomedicines: example of advancement in delivery;
- the French Technology Platform on Nanomedicine;
- regulatory aspects of nanomedicines;
- cell therapy.
The ETPN addresses ambitious, responsible research, development and innovation in nanotechnology for health with the aim of making Europe more competitive in the field of nanomedicine and improving the quality of life and health care of Europe's citizens.For further information, please visit:
http://etpn.zeltia.com/(opens in new window)